Aardvark Therapeutics Corp (AARD): Rega marang dodolan

Logo korporat perusahaan Aardvark Therapeutics Corp (AARD)

Aardvark Therapeutics Inc (AARD) is developing scientific partnerships with medical centers to combat genetic pathologies. The unique mechanisms of action of its small-molecule compounds enable the company to operate effectively within a high-capacity segment. The P/S ratio history illustrates the business valuation trend, where determines the current status of the parameter. This helps assess the potential of the biotech firm, which is developing treatments for obesity and Prader-Willi syndrome for a broad patient population.

Aardvark Therapeutics - Multiplikator P/S AARD (periode 04.07.2022 - 17.11.2026)

Rincian metrik lan analitis perusahaan aardvarktherapeutics.com (AARD)

Analisis umum perusahaan:AARD Aardvark Therapeutics
Barang utama Aardvark Therapeutics Inc

The resilience of Aardvark Therapeutics Inc (AARD) is driven by the success of clinical trials for obesity drugs, which directly impacts market capitalization relative to sales volume. This price-to-sales ratio measures the business value per unit of revenue, helping investors identify asset overvaluation by comparing current values with historical lows and highs on this chart.

Perusahaan pesaing

Rasio rega marang pendapatan ASND (Ascendis Pharma AS)|Rasio rega marang pendapatan madrigalpharma.com MDGL|Corcept Therapeutics Corp (CORT) - Rega marang dodolan|RYTM - Rasio rega marang pendapatan|AKRO: Rasio rega marang pendapatan|MTSR: Multiplikator P/S|MLTX - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Crinetics Corp|NewAmsterdam Pharma Corp (NAMS) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan soleno.life (SLNO)|Kapitalisasi marang pendapatan Amicus Therapeutics FOLD|Rasio kapitalisasi pasar marang pendapatan 89bio Inc|Multiplikator P/S Agios Pharmaceuticals, Inc. AGIO|GPCR: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan MiMedx Corp MDXG|RZLT (Rezolute Corp) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan LXRX|MBX (MBX Biosciences) - Multiplikator P/S|Kapitalisasi marang pendapatan Altimmune Inc (ALT)|Rasio rega marang pendapatan Sagimet Biosciences Inc (SGMT)|BioAge Labs Inc. (BIOA) - Multiplikator rega marang pendapatan|Multiplikator P/S BMEA (Biomea Fusion Corp)|quincetx.com (QNCX) - Rega marang dodolan|GUTS - Rasio rega marang pendapatan|Rega marang dodolan vTv Therapeutics|ATPC (agapeatpgroup.com) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan PLUR|Kapitalisasi marang pendapatan SYBX|LPCN: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S MTNB|SPRB - Rega marang dodolan|Multiplikator P/S GLTO (Galecto Corporation)|Rasio kapitalisasi pasar marang pendapatan CTCX|Lumos Therapeutics - Multiplikator P/S|ONVO: Rasio rega marang pendapatan|Radius Recycling (RDUS) - Rasio rega marang pendapatan